Regional Monitoring EECA
by ECUO PLWH
Showing 1-32 of 32 items.
Excel
#CountrySource of financingManufacturerTradenameINNFormPrice per unit ($)Units in purchaseUnits in packagePrice per package ($)Packages in purchasePrice per purchase ($)DistributorYearPurchase dateDelivery dateRegisteredIn the list of main (vital) medicationsWHO prequalification
1Republic of TajikistanGlobal FundViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab0.5167303015.5115.52015Not specifiedNot specifiedNot specified
2Republiс of AzerbaijanGovernmentViiV HealthcareAbacavir+Lamivudine - FDC600mg+300mg tab1.7167219603051.5732376982015YesYesNot specified
3Republic of MoldovaGovernmentViiv Healthcare UK LimitedZiagenAbacavir+Lamivudine - FDC600mg+300mg tab5.81672487030174.5829144660.5Dita Estfarm SRLNot specifiedNot specifiedNot specified
4UkraineGlobal FundGlaxoSmithKlineKivexaAbacavir+Lamivudine - FDC600mg+300mg tab0.9696291003029.0720970609597.882016YesYesNot specified
5Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550403016.951682847.62015Not specifiedYesNot specified
6Republic of LatviaGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.6193030348.571348.572015Not specifiedNot specifiedNot specified
7Russian FederationGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab1.83600030541200648002016YesYesNot specified
8Republic of TajikistanGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.4667900003014300042000UNDP/UNICEF2016Not specifiedNot specifiedNot specified
9Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.43331590301353689VPP, through Partnership for Supply Chain Management (PFSCM)20152015-03-112015-10-14Not specifiedNot specifiedNot specified
10Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166719500030425650027625002015Not specifiedNot specifiedNot specified
11Republic of PolandGovernmentSandozAbacavir + Lamivudine SandozAbacavir+Lamivudine - FDC600mg+300mg tab8.37535100030251.261700427142Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
12GeorgiaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.4163263703012.4987910978.71partnership for supply. chain management (PFSCM)2016YesYesNot specified
13Republic of LithuaniaInsurance FundViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab7.51933030225.581225.582016YesYesNot specified
14Republic of LithuaniaGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab11.13733030334.121334.12Viiv Healthcare UK Limited2015Not specifiedYesNot specified
15UkraineGlobal FundGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab1.02303030.6130.62015Not specifiedNot specifiedNot specified
16Republic of PolandGovernmentGlaxoSmithKlineKivexaAbacavir+Lamivudine - FDC600mg+300mg tab12.882300030386.4610038646Krajowe Centrum ds. AIDS2016YesYesNot specified
17Republic of KazakhstanGovernmentAurobindo Pharma Ltd.Abacavir+LamivudimAbacavir+Lamivudine - FDC600mg+300mg tab0.0630301.811.82016YesNot specifiedYes
18Russian FederationGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab4.002436197030120.06145399174566042015Not specifiedNot specifiedNot specified
19Kyrgyz RepublicGlobal FundAurobindo Pharma Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.5167-3015.5--UNDP/UNICEF20152014-12-312015-12-30Not specifiedNot specifiedNot specified
20UkraineGovernmentGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab0.97971719303029.395731168434.092015Not specifiedNot specifiedNot specified
21UkraineGovernmentAurobindo Pharma Ltd.Abacavir+LamivudimAbacavir+Lamivudine - FDC600mg+300mg tab0.40431719303012.13573169517.032016YesYesYes
22Republic of MoldovaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.565101103016.953375712.15IDA Foundation2016Not specifiedNot specifiedNot specified
23Republic of MoldovaGlobal FundHetero labs Ltd.Abacavir+Lamivudine - FDC600mg+300mg tab0.56550703016.951692864.55IDA Foundation2015Not specifiedYesNot specified
24Republic of PolandGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.166718000304256002550002015Not specifiedNot specifiedNot specified
25Republic of LatviaGovernmentViiv Healthcare UK LimitedKivexaAbacavir+Lamivudine - FDC600mg+300mg tab13.18819776030395.6465922608059National Health Service (NHC)2016Not specifiedNot specifiedNot specified
26Republic of ArmeniaGlobal FundMYLAN LABORATORIES LTDAbacavir+Lamivudine - FDC600mg+300mg tab0.416382203012.492743422.26partnership for supply. chain management (PFSCM)2016NoYesNot specified
27UkrainePEPFARMYLAN LABORATORIES LTDAbacavir (ABC)Abacavir+Lamivudine - FDC600mg+300mg tab0.37339664803011.232216360819.192016YesNot specifiedNot specified
28Republic of PolandGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab14.1667660003042522009350002015Not specifiedNot specifiedNot specified
29Republic of PolandGovernmentGlaxoSmithKlineKivexaAbacavir+Lamivudine - FDC600mg+300mg tab12.88213800030386.4646001777716Krajowe Centrum ds. AIDS2016Not specifiedNot specifiedNot specified
30GeorgiaGlobal FundGlaxoSmithKlineAbacavir+Lamivudine - FDC600mg+300mg tab1.9667494403059164897232partnership for supply. chain management (PFSCM)2016YesYesNot specified
31Republic of LithuaniaInsurance FundTeva BVKivexaAbacavir+Lamivudine - FDC600mg+300mg tab7.57473030227.241227.242016YesYesYes
32Republic of KazakhstanGovernmentViiV HealthcareKivexaAbacavir+Lamivudine - FDC600mg+300mg tab0.377730474003011.331015801150901.382015Not specifiedNot specifiedNot specified